BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer

Michael J. Pishvaian, Andrew V. Biankin, Peter Bailey, David K. Chang, Daniel Laheru, Christopher L. Wolfgang, Jonathan R. Brody

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences